| 423.97 Delayed Data As of Feb 15 |  +9.00 / +2.17%Today’s Change | 281.89 Today|||52-Week Range 431.32 | +13.51% Year-to-Date |
| Previous close | 414.97 |
| Today’s open | 417.97 |
| Day’s range | 415.72 - 424.39 |
| Volume | 700,044 |
| Average volume (3 months) | 762,629 |
| Market cap | $44.9B |
| Earnings growth (last year) | +42.53% |
| Earnings growth (this year) | +0.32% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +14.28% |
| P/E ratio | 19.9 |
| Price/Sales | 6.39 |
| Price/Book | 5.20 |
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +0.99 | +1.37% |
| VRTXVertex Pharmaceutica... | +2.35 | +1.27% |
| ZTSZoetis Inc | +2.11 | +2.26% |
| ALXNAlexion Pharmaceutic... | +3.49 | +2.77% |
| Next reporting date | May 6, 2019 |
| EPS forecast (this quarter) | $5.28 |
| Annual revenue (last year) | $6.7B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 36.42% |
Sector Health Technology |
Industry Biotechnology |
Co-President, Chief Executive Officer & Director Leonard S. Schleifer |
Co-President, Director & Chief Scientific Officer George Damis Yancopoulos |
Corporate headquarters Tarrytown, New York |
